Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients? [Investor's Business Daily]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Investors Business Daily
Related news 3/13/2019 IBD’s top-performing stock lists have just been updated. See which stocks got added – and which got cut. Could A Patent Battle Force Sanofi To Snap Up This Biotech Stock? Stocks Showing Improved Relative Strength: Sanofi The Top 5 Biotech Stocks Are Facing Growth Challenges — Are Any Immune? IBD 50 Stock List Welcomes CoreSite Realty, Regeneron This Is One Company That Could Break Up Bristol-Celgene Deal Teva Expects To Hit Bottom In 2019 — Stock Dives On Lagging Outlook Is Big Pharma Poised For A 2019 Buying Spree In Biotech Stocks? Essent, UnitedHealth Join IBD 50; Stock Spotlight Welcomes 5 Newbies Biotech giant Amgen ( AMGN ) could expand the market for Repatha by 4.5 million patients with high cholesterol if the PCSK9 inhibitor proves its mettle in a new study, an analyst said Friday. On Wednesday, Amgen announced it's conducting a new test for Repatha aimed to lower the risk of death, heart attack, stroke or
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia APR Newswire
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A [Yahoo! Finance]Yahoo! Finance
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia APR Newswire
- Excess Deaths In Japan Hit 115,000 Following 3rd COVID Shot; New Study Explains Why [zero hedge]zero hedge
- Bankruptcy allowed Mallinckrodt to end Acthar royalties, 3rd Circ. rules [Reuters]Reuters
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- 4/4/24 - Form S-8
- SNY's page on the SEC website